期刊文献+

乳腺浸润性导管癌伴广泛导管内癌保乳术后局部复发的影响因素分析

Influencing factor analysis of local recurrence of breast invasive ductal carcinoma with extensive intraductal carcinoma after breast conserving surgery
下载PDF
导出
摘要 目的探讨乳腺浸润性导管癌(invasive ductal carcinoma,IDC)伴广泛导管内癌(extensive intraductal carcinoma,EIC)组织血管细胞黏附因子-1(vascular cell adhesion molecule-1,VCAM-1)与生存素(survivin)对保乳术后局部复发的影响。方法选择2014年2月至2016年3月徐州医科大学附属沭阳医院收治的拟行保乳术治疗的乳腺IDC伴EIC患者179例,所有患者采用保乳术治疗,术中采集癌组织与癌旁组织。采用免疫组化法检测癌组织与癌旁组织VCAM-1与survivin表达水平。随访5年,根据是否局部复发分为复发组与未复发组。采用多因素logistic回归分析对乳腺IDC伴EIC患者术后局部复发的影响因素进行分析。结果179例患者中,171例完成5年随访,随访率95.5%,其中复发组38例,未复发组133例。乳腺IDC伴EIC患者癌组织中VCAM-1与survivin表达阳性率高于癌旁组织(74.9%比13.4%,60.9%比10.1%),差异有统计学意义(P<0.001)。复发组淋巴结转移占比、免疫分型为基底细胞样型占比、癌组织中VCAM-1阳性占比、survivin阳性占比、CK5/CK6阳性占比显著高于未复发组(68.4%比24.1%,68.4%比26.3%,92.1%比69.9%,89.5%比54.1%,84.2%比18.8%),差异均有统计学意义(P<0.05);复发组癌组织中ER和PR阴性占比显著高于未复发组(57.9%比31.6%,68.4%比36.1%),差异有统计学意义(P<0.05);多因素logistic回归分析显示,免疫分型为基底细胞样型(OR=2.759,95%CI:1.135~6.706)、癌组织中VCAM-1阳性(OR=2.790,95%CI:1.148~6.780)和survivin阳性(OR=2.878,95%CI:1.184~6.994)为乳腺IDC伴EIC患者术后局部复发的危险因素(P<0.001)。结论免疫分型为基底细胞样型、癌组织中VCAM-1阳性、survivin阳性为乳腺IDC伴EIC患者保乳术后局部复发的危险因素。 Objective To investigate the effect of vascular cell adhesion molecule-1(VCAM-1)and survivin on local recurrence of breast invasive ductal carcinoma(IDC)with extensive intraductal carcinoma(EIC)after breast conserving surgery.Methods From February 2014 to March 2016,179 patients with breast IDC and EIC underwent breast conserving surgery were selected as the research objects.During the operation,carcinoma tissue and para-carcinoma tissue of all patients were collected,immunohistochemistry was used to detect the levels of VCAM-1and survivin.Followed up for five years,the patients were divided into recurrence group and non-recurrence group.General information of the patients were collected.Logistic regression analysis was used to analyze the influencing factors of postoperative local recurrence in the patients with breast IDC and EIC.Results Among 179 patients with breast IDC and EIC,eight patients were lost during follow-up,the follow up rate was 95.5%.The positive rates of VCAM-1 and survivin were higher in carcinoma tissue than those in para-carcinoma tissue(74.9%vs.13.4%,P<0.001;60.9%vs.10.1%,P<0.001).Compared with the non-recurrence group,the proportion of lymphatic metastasis(68.4%vs.24.1%),basaloid-like type(68.4%vs.26.3%),VCAM-1 positive(92.1%vs.69.9%),survivin positive(89.5%vs.54.1%),CK5/CK6 positive(84.2%vs.18.8%)in the recurrence group were significantly higher(P<0.05).The proportion of ER-negative cases(57.9%vs.31.6%)and PR-negative cases(68.4%vs.36.1%)in the recurrence group was higher than that in the non-recurrence group(P<0.05).Logistic regression analysis showed that basaloid-like type(OR=2.759,95%CI:1.135-6.706,P<0.001),positive VCAM-1(OR=2.790,95%CI:1.148-6.780,P<0.001)and positive survivin(OR=2.878,95%CI:1.184-6.994,P<0.001)in carcinoma tissue were risk factors for postoperative local recurrence in the patients with breast IDC and EIC.Conclusions Basaloid-like type,VCAM-1positive and survivin positive in carcinoma tissue were risk factors for local recurrence after breast conserving surgery in breast IDC patients with EIC.
作者 任船 赵鹏新 葛荣忠 Ren Chuan;Zhao Pengxin;Ge Rongzhong(Department of General Surgery,Shuyang Hospital Affiliated to Xuzhou Medical University,Suqian 223600,China)
出处 《北京医学》 CAS 2022年第4期303-307,共5页 Beijing Medical Journal
关键词 乳腺癌 浸润性导管癌 导管内癌 血管细胞黏附因子-1 生存素 保乳术 局部复发 预测价值 breast carcinoma invasive ductal carcinoma(IDC) intraductal carcinoma vascular cell adhesion molecule-1(VCAM-1) survivin breast-conserving surgery local recurrence predictive value
  • 相关文献

参考文献6

二级参考文献36

  • 1中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2011版)[J].中国癌症杂志,2011,21(5):367-417. 被引量:264
  • 2赵海鹰,田忠,森本忠兴,刘金钢,余云.乳腺癌广泛导管内癌成分与组织蛋白酶DKi-67及单链DNA表达的关系及临床意义[J].中国实用外科杂志,2006,26(4):277-279. 被引量:8
  • 3Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical On- cology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-blast irradiation in stages I and II invasive breast cancer [J]. Int J Radiat Oncol Biol Phys, 2014, 88(3):553-564.
  • 4Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical On- cology-Americ, an Society for Radiation Ontology consensus guideline on margins for breast-conserving surgery with whoLe-breast irradiation in stages I and II invasive breast cancer [J]. J Clin Oneol, 2014, [Epub ahead of print 1.
  • 5Moran MS, Schnitt SJ, Giuliano AE, et el. Society of Surgical On- cology-American Society for Radiation Ontology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages i and II invasive breast cancer [J]. Ann Surg Oncol, 2014, 21(3): 704-716.
  • 6王海明,王聪伟,李松林,许延发.Survivin、CyclinD1在大肠癌中的表达及其临床意义[J].中国微生态学杂志,2007,19(6):524-526. 被引量:3
  • 7Hanley KZ,Birdsong GG,Cohen C,et al.Immunohistochemical detection of estrogen receptor,progesterone receptor,and human epidermal growth factor receptor 2 expression in breast carcinomas:comparison on cell block,needle-core,and tissue block preparations[J].Cancer,2009,117(4):279-288.
  • 8Melet A,Song K,Bucur O,et al.Apoptotic pathways in tumor progression and therapy[J].Adv Exp Med Biol,2008,615:47-79.
  • 9Masuda H,Masuda N,Kodama Y,et al.Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triplenegative breast cancer patients[J].Cancer Chemother Pharmacol,2011,67(4):911-917.
  • 10Boykin C,Zhang G,Chen YH,et al.Cucurbitacin IIa:a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation[J].Br J Cancer,2011,104(5):781-789.

共引文献542

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部